Literature DB >> 6375932

Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate.

V Schulz.   

Abstract

Sodium nitroprusside decomposes within a few minutes after intravenous infusion to form metabolites which are pharmacologically inactive but toxicologically important. Free cyanide, which represents 44% w/w of the sodium nitroprusside molar mass, is formed and must be detoxified in the body into thiocyanate using thisulphate as substrate. Nitroprusside penetrates cell membranes slowly. At therapeutic dose levels its distribution is probably mainly extracellular. Contact with the sulfhydryl groups in the cell walls, however, immediately initiates breakdown of the molecule. Sodium nitroprusside taken orally is not absorbed from the gastrointestinal tract to any appreciable extent. Cyanides in the body form prussic acid, which can rapidly penetrate mucous and cell membranes. In the blood, about 99% of the prussic acid binds to the methaemoglobin of erythrocytes. At normal physiological levels, however, the total body methaemoglobin of an adult human can only bind about 10mg of prussic acid; this is a small fraction of the amounts usually infused therapeutically as sodium nitroprusside. The endogenous detoxification of prussic acid exhibits zero-order kinetics. The limiting factor is a sulphur donor, principally thiosulphate, which is available in the body in only limited amounts. The rate of spontaneous detoxification of prussic acid in humans is only about 1 microgram/kg/min, corresponding to a sodium nitroprusside infusion of about 2 microgram/kg/min. This dose limit set by the prussic acid toxicity of sodium nitroprusside can, however, be increased considerably by simultaneous infusion of thiosulphate. A lack of thiosulphate can be detected early by a rise of the prussic acid concentration in the erythrocytes. Thiosulphate taken orally is not absorbed by the body. After intravenous infusion, its serum half-life is about 15 minutes. Most of the thiosulphate is oxidised to sulphate or is incorporated into endogenous sulphur compounds; a small proportion is excreted through the kidneys. Thiocyanate taken orally is completely absorbed by the body. In healthy persons its volume of distribution is approximately 0.25 L/kg and the serum half-life about 3 days; elimination is mainly renal. Thiocyanate toxicity does not represent a serious therapeutic problem with intravenous infusion of sodium nitroprusside.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375932     DOI: 10.2165/00003088-198409030-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  68 in total

1.  Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients.

Authors:  I H PAGE; A C CORCORAN; H P DUSTAN; T KOPPANYI
Journal:  Circulation       Date:  1955-02       Impact factor: 29.690

2.  Studies on the metabolism of the carbon of cyanide and thiocyanate.

Authors:  G E BOXER; J C RICKARDS
Journal:  Arch Biochem Biophys       Date:  1952-07       Impact factor: 4.013

3.  The renal clearance of thiosulfate with observations on its volume distribution.

Authors:  A GILMAN; F S PHILIPS; E S KOELLE
Journal:  Am J Physiol       Date:  1946-06

4.  Nitroprusside produces cyanide poisoning via reaction with hemoglobin.

Authors:  R P Smith; H Kruszyna
Journal:  J Pharmacol Exp Ther       Date:  1974-12       Impact factor: 4.030

5.  Microdiffusion method for estimation of cyanide in whole blood and its application to the study of conversion of cyanide to thiocyanate.

Authors:  A R Pettigrew; G S Fell
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

6.  [Antidotes in cyanide poisoning].

Authors:  K D Friedberg
Journal:  Arch Toxikol       Date:  1968

7.  Fluorometric determination of cyanide in biological fluids and pyridoxal.

Authors:  R L Morgan; J L Way
Journal:  J Anal Toxicol       Date:  1980 Mar-Apr       Impact factor: 3.367

8.  Inhibition of mitochondrial respiration by sodium nitroprusside and the mechanism of cyanide liberation.

Authors:  S Nakamura; T Shin; Y Hirokata; A Shigematsu
Journal:  Br J Anaesth       Date:  1977-12       Impact factor: 9.166

9.  [Therapy of cyanide poisoning using 4-dimethylaminophenol (4-DMAP). Report on a case of poisoning in man].

Authors:  M Daunderer; H Theml; N Weger
Journal:  Med Klin       Date:  1974-10-04

10.  Some physiological and metabolic effects of sodium nitroprusside and cyanide in the dog.

Authors:  P J Simpson; L Adams; C J Vesey; P Cole
Journal:  Br J Anaesth       Date:  1979-02       Impact factor: 9.166

View more
  19 in total

1.  A dual role of the transcriptional regulator TstR provides insights into cyanide detoxification in Lactobacillus brevis.

Authors:  Fernando A Pagliai; Caitlin C Murdoch; Sara M Brown; Claudio F Gonzalez; Graciela L Lorca
Journal:  Mol Microbiol       Date:  2014-04-14       Impact factor: 3.501

2.  Sodium Nitrite and Sodium Thiosulfate Are Effective Against Acute Cyanide Poisoning When Administered by Intramuscular Injection.

Authors:  Vikhyat S Bebarta; Matthew Brittain; Adriano Chan; Norma Garrett; David Yoon; Tanya Burney; David Mukai; Michael Babin; Renate B Pilz; Sari B Mahon; Matthew Brenner; Gerry R Boss
Journal:  Ann Emerg Med       Date:  2016-12-29       Impact factor: 5.721

Review 3.  Drug treatment of hypertensive crisis in children.

Authors:  Christopher A Thomas
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

Review 4.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 5.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

6.  Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers.

Authors:  Stefan Farese; Emilie Stauffer; Robert Kalicki; Tatjana Hildebrandt; Brigitte M Frey; Felix J Frey; Dominik E Uehlinger; Andreas Pasch
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

7.  Proceedings of the British Pharmacological Society. Amsterdam, 2nd-4th July 1986. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

8.  Effect of hyperbaric oxygen therapy on whole blood cyanide concentrations in carbon monoxide intoxicated patients from fire accidents.

Authors:  Pia Lawson-Smith; Erik C Jansen; Linda Hilsted; Ole Hyldegaard
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-06-15       Impact factor: 2.953

9.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Biochem Pharmacol       Date:  2012-08-08       Impact factor: 5.858

10.  Cyanide poisoning in the post-transplantation patient-a cautionary tale.

Authors:  Catherine Quinlan; Denis Gill; Mary Waldron; Atif Awan
Journal:  Pediatr Nephrol       Date:  2008-08-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.